Black Diamond Therapeutics
BDTX
BDTX
112 hedge funds and large institutions have $705M invested in Black Diamond Therapeutics in 2021 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 31 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
9% less call options, than puts
Call options by funds: $1.2M | Put options by funds: $1.32M
23% less capital invested
Capital invested by funds: $915M → $705M (-$210M)
Holders
112
Holding in Top 10
–
Calls
$1.2M
Puts
$1.32M
Top Buyers
| 1 | +$23.6M | |
| 2 | +$20.4M | |
| 3 | +$10.4M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$6.69M |
| 5 |
Axa
Paris,
France
|
+$6.44M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$13.5M | |
| 3 | -$11.7M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$10.5M |
| 5 |
CC
Casdin Capital
New York
|
-$9.28M |